Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor. It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder. It has since received approval for a variety of indications including the tre...
Indicated for:
1) Management of Major Depressive Disorder.
2) Management of Generalized Anxiety Disorder.
3) Management of diabetic peripheral neuropathy.
4) Management of fibromyalgia.
5) Management of chronic musculoskeletal pain.
6) Management of osteoarthritis of the knee in adults.
7) Management of chronic lower back pain in adults.
...
University of Kentucky Medical Center, Lexington, Kentucky, United States
Jacobi Medical Center, Bronx, New York, United States
University of Rochester, Rochester, New York, United States
Honor Health, Scottsdale, Arizona, United States
University of North Texas Health Science Center, Fort Worth, Texas, United States
Bezirkskrankenhaus Augsburg, Augsburg, Germany
Krankenhaus Hedwigshöhe, Berlin, Germany
Hannover Medical School, Hannover, Germany
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.